You’ve read the news and seen the countless headlines. Here’s your chance to ask about delta-8 and its place in a licensed cannabis or hemp business plan.
We’ll be talking about other emerging cannabinoids, too, so you can be prepared for this conversation in the next iteration.
In tomorrow’s webinar, hear from Greg Gerdeman, president and CSO of NASHCX, and Justin Walsh, partner at Gleam Law, who will walk you through the scientific and legal ramifications of delta-8. You will learn the context behind this cannabinoid and the opportunities that accompany emerging consumer trends like this one. |
